Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Clinical trial NCT04146051 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04146051
- Sponsor
- Cartesian Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-04
- Primary completion
- 2026-01-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.